Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

Phase 2

Completed

Conditions: CNS Cancer
Intracranial Hemangiopericytoma
Meningioma
Hemangioblastoma
Neurofibromatosis

Interventions: Drug: Sunitinib

First Posted Date: 2008-01-10

Last Posted Date: 2016-01-25

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 50

Registration Number: NCT00589784

Locations: 🇺🇸
University of Virginia Health Science Center, Charlottesville, Virginia, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center at Commack, Commack, New York, United States

and more 3 locations

Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer

Completed

Conditions: Breast Cancer

Interventions: Other: Blood test
Other: Questionnaire

First Posted Date: 2008-01-10

Last Posted Date: 2021-12-28

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 383

Registration Number: NCT00590109

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Menstrual Cycle Maintenance and Quality of Life: A Prospective Study

Active, not recruiting

Conditions: Breast Cancer
Menstrual Cycle
Amenorrhea

Interventions: Other: Questionnaire

First Posted Date: 2008-01-10

Last Posted Date: 2025-01-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 810

Registration Number: NCT00589654

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Long Term Follow-Up of Patients on Children's Cancer Group Protocols- (CCG-LTF1) FOLLOW-UP DATA

Completed

Conditions: Oncology
Pediatric Cancers

First Posted Date: 2008-01-08

Last Posted Date: 2013-10-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 102

Registration Number: NCT00588289

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

The Communication of Genetic Risk to Adolescent Daughters of Women With Breast Cancer

Completed

Conditions: Counseling
Breast Cancer

Interventions: Behavioral: focus group & questionaire

First Posted Date: 2008-01-08

Last Posted Date: 2017-01-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 27

Registration Number: NCT00588705

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Study of D-Methadone in Patients With Chronic Pain

Phase 1

Completed

Conditions: Pain
CNS Cancer
Eye Cancer
Otorhinolaryngologic Neoplasms
Bladder Cancer
Esophageal Cancer
Pancreatic Cancer
Breast Cancer
Colon Cancer
Prostate Cancer

Interventions: Drug: D-methadone
Drug: placebo

First Posted Date: 2008-01-08

Last Posted Date: 2016-08-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 10

Registration Number: NCT00588640

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer

Not Applicable

Completed

Conditions: Breast Cancer
Osteoporosis

Interventions: Other: Bone Mineral Density

First Posted Date: 2008-01-08

Last Posted Date: 2009-02-26

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 7

Registration Number: NCT00587925

Locations: 🇺🇸
Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Estrogen, Diet, Genetics and Endometrial Cancer

Active, not recruiting

Conditions: Cancer
Endometrial Cancer
Corpus Uteri
Ovarian Cancer
Endometrium

Interventions: Behavioral: Questionnaire

First Posted Date: 2008-01-08

Last Posted Date: 2024-01-25

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1315

Registration Number: NCT00587886

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)

Phase 2

Completed

Conditions: Hodgkin's Disease

Interventions: Drug: Methotrexate
Drug: Leucovorin calcium
Drug: 6-Thioguanine

First Posted Date: 2008-01-08

Last Posted Date: 2009-06-12

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 18

Registration Number: NCT00587873

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Utility of PET In the Pre-Operative Assessment of Patients With Hepatic Colorectal Metastases

Completed

Conditions: Colorectal Carcinoma

First Posted Date: 2008-01-08

Last Posted Date: 2009-03-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 204

Registration Number: NCT00588549

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy